Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00523185 · ClinicalTrials.gov registry record · NA
A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal
A NA study of Alcohol Withdrawal, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 2
- Study locations
NCT00523185 is a NA study of Alcohol Withdrawal that has completed, run by Stanford University. The registered enrollment target is 55 participants, below the 80-participant average among 3 other Alcohol Withdrawal trials with a reported enrollment target (31% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00523185, a NA study of Alcohol Withdrawal, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to compare the efficacy of two commonly used medications in the treatment of alcohol withdrawal, diazepam and lorazepam.
Conditions Studied
Interventions
- DRUG Lorazepam
- DRUG Diazepam
Study Locations (2)
California
- Palo Alto Veterans Affairs Hospital System - Palo Alto
- Stanford Hospital and Clinics - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2003-05 |
| Est. Completion | 2004-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00523185
The ClinicalTrials.gov registry entry for NCT00523185 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 80-participant average among 3 other Alcohol Withdrawal trials with a reported enrollment target (31% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alcohol Withdrawal appearing as the primary indexed condition, and to 2 interventions - of which Lorazepam is the first listed.
NCT00523185 reports 2 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT00523185 about?
NCT00523185 is a clinical study titled "A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal". The purpose of this study is to compare the efficacy of two commonly used medications in the treatment of alcohol withdrawal, diazepam and lorazepam.
What is the current status of trial NCT00523185?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2003-05. Estimated completion is 2004-11.
What conditions does trial NCT00523185 study?
This clinical trial studies the following conditions: Alcohol Withdrawal.
What interventions are being tested in trial NCT00523185?
The interventions under investigation include: Lorazepam (DRUG), Diazepam (DRUG).
Who is sponsoring clinical trial NCT00523185?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00523185 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Withdrawal
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.